Sun, Dec 28, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Regulators look more closely at non-bank lending as hedge funds, investors see opportunity

Wednesday, April 03, 2013

Bailey McCann, Opalesque New York:

Non-bank lending, or shadow banking has been an area of concern for regulators since the crisis. However, allocators, hedge funds and businesses, are looking to the space more and more, as liquidity in more traditional banking spaces dries up. This reality is true worldwide, causing regulators to try and find ways to limit the scope of shadow banking. However, they may find little support for new rules even in the public.

Global demand

Shadow banking has long been a space without much regulation, or even much public awareness of its existence. Since the crisis, shadow banking has taken on a more public profile, and arguably a more significant role in the global financial system. "Capital requirements, regulation, and deal size have made banks not to lend without significant provisioning," said Alfredo González, Co-Fund Manager, LW Short Duration Fund, in an interview with Opalesque. He noted that because of new rules on traditional banks, those banks want bigger deals, with better, creditworthier entities often at the expense of smaller, but still sound ones. LW Asset Management, the firm that manages the LW Short Duration Fund, is focused on Latin America. Middle market Latin American businesses have seen many credit options dry up in the wake of the crisis, creating a significant demand for non-b......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its